Patient Leaflet Updated 11-May-2026 | Aurobindo Pharma - Milpharm Ltd.
Tamoxifen 20mg Tablets
Tamoxifen 20 mg Tablets
1. What Tamoxifen Tablets are and what they are used for
2. What you need to know before you take Tamoxifen Tablets
3. How to take Tamoxifen Tablets
4. Possible side effects
5. How to store Tamoxifen Tablets
6. Contents of the pack and other information
Tamoxifen belongs to a group of medicines called ‘anti-oestrogens’.
If you want to know more about how to decide whether tamoxifen is right for you, there is more information for patients on the National Institute of Health and Care Excellence website. Ask your doctor to talk to you about the information which is available for patients.
Oestrogen is a natural substance in your body known as a ‘sex hormone’. Some breast cancers need oestrogen to grow and Tamoxifen works by blocking the effects of oestrogen.
Do not take Tamoxifen Tablets if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Tamoxifen Tablets.
Talk to your doctor or pharmacist before taking Tamoxifen.
In delayed breast reconstruction operation (weeks to years after the primary breast operation when your own tissue is moved to shape a new breast) Tamoxifen may increase the risk of the formation of blood clots in the small vessels of the tissue flap which may lead to complications.
Studies in premenopausal women who took tamoxifen for reduction of breast cancer risk or for treatment of breast cancer have reported decreases in bone density. If you are a premenopausal woman undergoing treatment with Tamoxifen, ask your doctor for advice about ways to maintain your bone health.
Tamoxifen therapy may be used to reduce the risk of breast cancer and it can be associated with serious side effects such as blood clots in the veins of your leg (deep vein thrombosis), blood clots in your lungs (pulmonary embolus) and uterine cancer, all of which can be fatal. Other less serious side effects such as hot flushes, vaginal discharge, menstrual irregularities and pelvis pain may also occur.
Whether the benefits of treatment outweigh the risks depends on your age, health history, your level of breast cancer risk and on your personal judgement. Tamoxifen therapy to reduce the risk of breast cancer may not be appropriate for all women at increased risk. All assessments with your healthcare professional of the potential benefits and risks prior to starting therapy are essential. You should understand that Tamoxifen reduces, but does not eliminate the risk of breast cancer.
If you have or have had heart problems or an irregular heartbeat (arrhythmia), you may be at a higher risk of changes in your heart’s electrical activity (known as QT prolongation) when using tamoxifen. QT prolongation can be seen on a heart test called an electrocardiogram (ECG) and may increase the risk of serious heart rhythm problems. If you are at an increased risk, your doctor should check your blood for important blood salts and minerals (electrolytes) and check your heart activity with an ECG before and during treatment with tamoxifen.
If you have a history of hereditary angioedema as Tamoxifen may cause or worsen symptoms of hereditary angioedema. If you experience symptoms such as swelling of the face, lips, tongue and/or throat with difficulty in swallowing or breathing, contact a doctor immediately.
If you have any heart conditions including heart rhythm problems (arrhythmia), including a condition called Long QT syndrome (QT interval prolongation), the risk of heart rhythm problems may be increased when using Tamoxifen.
Serious skin reactions
Serious skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported in association with Tamoxifen treatment. Stop using Tamoxifen and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.
If you are to undergo planned surgery, you should tell your doctor or pharmacist as they may wish to consider stopping your treatment for a short period.
This medicine is not for use in children.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This is because Tamoxifen can affect the way some other medicines work and some medicines can have an effect on Tamoxifen.
In particular, tell your doctor or pharmacist if you are taking any other medicines:
Women who can become pregnant should use adequate non-hormonal contraception (e.g., barrier contraception) during treatment with Tamoxifen and for an additional nine months after stopping treatment.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Breast-feeding
Talk to your doctor before taking Tamoxifen tablets if you are breast-feeding.
Tamoxifen Tablets are not likely to affect your ability to drive or use any tools or machines. However, tiredness has been reported with the use of Tamoxifen Tablets and caution should be observed when driving or operating machinery while such symptoms persist.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.
Always take Tamoxifen Tablets exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
For oral use only. Swallow the tablets with a glass of water.
The recommended dose for breast cancer is 20 mg tablet daily.
The dose for infertility depends on your periods (menstrual cycle).
The recommended dose for reducing the risk of breast cancer is 20 mg daily for 5 years. Your healthcare professional will calculate your risk of breast cancer occurring using information about you, your medical history and any family history of breast cancer.
If you take more Tamoxifen tablets than you should, contact your doctor, pharmacist or nearest hospital casualty department immediately. Take this leaflet and any remaining tablets with you, if possible.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Tamoxifen Tablets can cause side effects, although not everybody gets them.
Very Common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very Rare (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side affects you can help provide more information on the safety of this medicine
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
Store below 25°C. Keep in the original package, away from light and moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is tamoxifen (as citrate), 20mg per tablet.
The other ingredients are calcium hydrogen phosphate, microcrystalline cellulose, sodium starch glycollate (Type A), povidone K25, magnesium stearate and colloidal anhydrous silica.
The tablets are white to off-white colored, round, biconvex, with scoring and ‘20’ embossed on one side. They are available in blister packs of 30 tablets.
This leaflet was last revised in 05/2026.
Ref: Ver 2.0
P15XXXXX
Milpharm Limited, 1 Roundwood Avenue, Stockley Park, Uxbridge, UB11 1AF, UK
+ 44 (0)208 845 8811
+44 (0)208 845 8811
http://www.aurobindo.com
+44 (0)208 845 8795